Brixadi: 5 Things to Know About This Medication for Addiction Treatment
By Katie Sebring, LPC, M.Ed. Katie Sebring, LPC, M.Ed. Meet The Editorial Team Author BrightView News BrightView News read more Published: March 6, 2024 Updated: March 6, 2024 Brixadi is a monthly injectable medication for use in treating opioid use disorders (OUDs). Available since 2023, it is similar to Sublocade – another medication for addiction treatment (MAT). Both medications contain buprenorphine and are extended release. Buprenorphine helps reduce cravings and withdrawal symptoms associated with opioid dependence. Morgan Hoover, a Nurse Practitioner at BrightView’s Sandusky, Ohio center says, “We are adding…
Details